Literature DB >> 32346091

Neutralizing antibody response in mild COVID-19.

Verena van der Heide1.   

Abstract

Entities:  

Year:  2020        PMID： 32346091      PMCID： PMC7186944          DOI： 10.1038/s41577-020-0325-2

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN： 1474-1733            Impact factor:   53.106


× No keyword cloud information.
  9 in total

1.  Seroprevalence of IgG antibodies against SARS-CoV-2 - a serial prospective cross-sectional nationwide study of residual samples, Belgium, March to October 2020.

Authors:  Sereina Annik Herzog; Jessie De Bie; Steven Abrams; Ine Wouters; Esra Ekinci; Lisbeth Patteet; Astrid Coppens; Sandy De Spiegeleer; Philippe Beutels; Pierre Van Damme; Niel Hens; Heidi Theeten
Journal:  Euro Surveill       Date:  2022-03

2.  The early detection of immunoglobulins via optical-based lateral flow immunoassay platform in COVID-19 pandemic.

Authors:  Pang-Yen Chen; Cheng-Hao Ko; C Jason Wang; Chien-Wei Chen; Wei-Huai Chiu; Chitsung Hong; Hao-Min Cheng; I-Jen Wang
Journal:  PLoS One       Date:  2021-07-20       Impact factor: 3.240

3.  Longitudinal Dynamics of the Neutralizing Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.

Authors:  Kai Wang; Quan-Xin Long; Hai-Jun Deng; Jie Hu; Qing-Zhu Gao; Gui-Ji Zhang; Chang-Long He; Lu-Yi Huang; Jie-Li Hu; Juan Chen; Ni Tang; Ai-Long Huang
Journal:  Clin Infect Dis       Date:  2021-08-02       Impact factor: 9.079

4.  Blockade of SARS-CoV-2 spike protein-mediated cell-cell fusion using COVID-19 convalescent plasma.

Authors:  Ling Wang; Juan Zhao; Lam N T Nguyen; James L Adkins; Madison Schank; Sushant Khanal; Lam N Nguyen; Xindi Dang; Dechao Cao; Bal Krishna Chand Thakuri; Zeyuan Lu; Jinyu Zhang; Yi Zhang; Xiao Y Wu; Mohamed El Gazzar; Shunbin Ning; Jonathan P Moorman; Zhi Q Yao
Journal:  Sci Rep       Date:  2021-03-10       Impact factor: 4.379

5.  Quantitative Spectrochip-Coupled Lateral Flow Immunoassay Demonstrates Clinical Potential for Overcoming Coronavirus Disease 2019 Pandemic Screening Challenges.

Authors:  Kai-Feng Hung; Chih-Hsing Hung; Chitsung Hong; Szu-Chia Chen; Yi-Chen Sun; Jyun-Wei Wen; Chao-Hung Kuo; Cheng-Hao Ko; Chao-Min Cheng
Journal:  Micromachines (Basel)       Date:  2021-03-18       Impact factor: 2.891

6.  Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Recovery from Mild Coronavirus Disease 2019.

Authors:  Jee-Soo Lee; So Yeon Kim; Taek Soo Kim; Ki Ho Hong; Nam-Hee Ryoo; Jaehyeon Lee; Jae Hyeon Park; Sung Im Cho; Man Jin Kim; Young-Gon Kim; Boram Kim; Ho Seob Shin; Hyeon Sae Oh; Myoung-Seock Seo; Tae-Rin Gwon; Yeonjae Kim; Jun-Sun Park; Bum Sik Chin; Wan Beom Park; Sung Sup Park; Moon-Woo Seong
Journal:  Clin Infect Dis       Date:  2020-11-21       Impact factor: 9.079

7.  Potent and Persistent Antibody Response in COVID-19 Recovered Patients.

Authors:  Xiaodong Tian; Ling Liu; Wenguo Jiang; He Zhang; Wenjun Liu; Jing Li
Journal:  Front Immunol       Date:  2021-05-28       Impact factor: 7.561

Review 8.  Dynamics of host immune responses to SARS-CoV-2.

Authors:  Reza Taherkhani; Sakineh Taherkhani; Fatemeh Farshadpour
Journal:  World J Clin Cases       Date:  2021-06-26       Impact factor: 1.337

9.  COVID-19 Antibody Detection and Assay Performance Using Red Cell Agglutination.

Authors:  Kshitij Srivastava; Kamille A West; Valeria De Giorgi; Michael R Holbrook; Nicolai V Bovin; Stephen M Henry; Willy A Flegel
Journal:  Microbiol Spectr       Date:  2021-12-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.